189 related articles for article (PubMed ID: 28815252)
1. [Expression of PTPRZ1 in oral squamous cell carcinoma originated from oral submucous fibrosis and its clinical significance].
Zhu R; Jian XC; Liu DY; Zhou C; Wang Y
Shanghai Kou Qiang Yi Xue; 2017 Apr; 26(2):198-203. PubMed ID: 28815252
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of programmed death-1 and its ligand, programmed death ligand-1 in oral squamous cell carcinoma with and without oral submucous fibrosis.
Quan H; Liu S; Shan Z; Liu Z; Chen T; Hu Y; Yao Z; Fang L
Arch Oral Biol; 2020 Nov; 119():104916. PubMed ID: 32977151
[TBL] [Abstract][Full Text] [Related]
3. [A retrospective study of oral squamous cell carcinomas originated from oral submucous fibrosis].
Guo F; Jian XC; Zhou SH; Li N; Hu YJ; Tang ZG
Zhonghua Kou Qiang Yi Xue Za Zhi; 2011 Aug; 46(8):494-7. PubMed ID: 22169748
[TBL] [Abstract][Full Text] [Related]
4. Ki67, CD105, and α-SMA Expression Supports Biological Distinctness of Oral Squamous Cell Carcinoma Arising in the Background of Oral Submucous Fibrosis.
Gadbail AR; Korde S; Chaudhary MS; Sarode SC; Gondivkar SM; Dande R; Tekade SA; Yuwanati M; Hande A; Patil S
Asian Pac J Cancer Prev; 2020 Jul; 21(7):2067-2074. PubMed ID: 32711434
[TBL] [Abstract][Full Text] [Related]
5. The phosphorylation of survivin Thr34 by p34cdc2 in carcinogenesis of oral submucous fibrosis.
Zhou S; Li L; Jian X; Ou X; Jiang H; Yao Z; Xu C; Peng J
Oncol Rep; 2008 Nov; 20(5):1085-91. PubMed ID: 18949405
[TBL] [Abstract][Full Text] [Related]
6. Expression and promoter methylation of Wnt inhibitory factor-1 in the development of oral submucous fibrosis.
Zhou S; Chen L; Mashrah M; Zhu Y; He Z; Hu Y; Xiang T; Yao Z; Guo F; Zhang C
Oncol Rep; 2015 Nov; 34(5):2636-42. PubMed ID: 26352791
[TBL] [Abstract][Full Text] [Related]
7. [Molecules of G(2)/M phase and the phosphorylation of survivin in the carcinogenesis of oral submucosal fibrosis].
Zhou SH; Li LL; Jian XC; Wang Y; Chen XQ; Gao X
Zhonghua Kou Qiang Yi Xue Za Zhi; 2008 Dec; 43(12):709-12. PubMed ID: 19134343
[TBL] [Abstract][Full Text] [Related]
8. MALDI imaging reveals NCOA7 as a potential biomarker in oral squamous cell carcinoma arising from oral submucous fibrosis.
Xie X; Jiang Y; Yuan Y; Wang P; Li X; Chen F; Sun C; Zhao H; Zeng X; Jiang L; Zhou Y; Dan H; Feng M; Liu R; Chen Q
Oncotarget; 2016 Sep; 7(37):59987-60004. PubMed ID: 27509054
[TBL] [Abstract][Full Text] [Related]
9. Expression pattern of DKK3, dickkopf WNT signaling pathway inhibitor 3, in the malignant progression of oral submucous fibrosis.
Zhou S; Zhu Y; Mashrah M; Zhang X; He Z; Yao Z; Zhang C; Guo F; Hu Y; Zhang C
Oncol Rep; 2017 Feb; 37(2):979-985. PubMed ID: 27959428
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.
Varun BR; Ranganathan K; Rao UK; Joshua E
J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of CK8 and CK18 in leukoplakia, oral submucous fibrosis, and oral squamous cell carcinoma: an immunohistochemistry study.
Nanda KD; Ranganathan K; Devi U; Joshua E
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Feb; 113(2):245-53. PubMed ID: 22677743
[TBL] [Abstract][Full Text] [Related]
12. Skewed Th17/Treg balance during progression and malignant transformation of oral submucous fibrosis.
Liu S; Liu Z; Shan Z; Liu Y; Chen T; Fang L; Quan H
Oral Dis; 2022 Nov; 28(8):2119-2130. PubMed ID: 33749974
[TBL] [Abstract][Full Text] [Related]
13. p16 as an independent marker for detection of high-risk HPV in oral submucous fibrosis and oral squamous cell carcinoma.
Sudhakaran A; Hallikeri K; Babu B
Indian J Pathol Microbiol; 2019; 62(4):523-528. PubMed ID: 31611434
[TBL] [Abstract][Full Text] [Related]
14. Study on the expression and function of smad family member 7 in oral submucous fibrosis and oral squamous cell carcinoma.
Hu X; Xiong H; Wang W; Huang L; Mao T; Yang L; Wang C; Huang D; Wu J; Xia K; Su T
Arch Oral Biol; 2020 Apr; 112():104687. PubMed ID: 32114253
[TBL] [Abstract][Full Text] [Related]
15. Relation of salivary MMP-8 with oral submucous fibrosis and oral squamous cell carcinoma: a cross sectional analytical study.
Kazmi A; Abbas Z; Saleem Z; Haider S; Farooqui WA; Ahmed S
BMJ Open; 2022 Dec; 12(12):e060738. PubMed ID: 36523229
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical study of p21 and Bcl-2 in leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma.
Sutariya RV; Manjunatha BS
J Exp Ther Oncol; 2016 Nov; 11(4):285-292. PubMed ID: 27849339
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical detection of human telomerase reverse transcriptase in oral cancer and pre-cancer.
Palani J; Lakshminarayanan V; Kannan R
Indian J Dent Res; 2011; 22(2):362. PubMed ID: 21891916
[TBL] [Abstract][Full Text] [Related]
18. Estimation of salivary matrix metalloproteinases- 12 (MMP- 12) levels among patients presenting with oral submucous fibrosis and oral squamous cell carcinoma.
Saleem Z; Shaikh AH; Zaman U; Ahmed S; Majeed MM; Kazmi A; Farooqui WA
BMC Oral Health; 2021 Apr; 21(1):205. PubMed ID: 33892690
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-1 beta in oral submucous fibrosis, verrucous hyperplasia and squamous cell carcinoma tissues.
Tsai CC; Chen CC; Lin CC; Chen CH; Lin TS; Shieh TY
Kaohsiung J Med Sci; 1999 Sep; 15(9):513-9. PubMed ID: 10561975
[TBL] [Abstract][Full Text] [Related]
20. Quantitative proteomic analysis for novel biomarkers of buccal squamous cell carcinoma arising in background of oral submucous fibrosis.
Liu W; Zeng L; Li N; Wang F; Jiang C; Guo F; Chen X; Su T; Xu C; Zhang S; Fang C
BMC Cancer; 2016 Aug; 16():584. PubMed ID: 27485544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
